Financial
FY2025 revenue C$15.91bn (+8.4%); pre-tax margin 14.1%; net income C$1.66bn.
Net debt C$3.45bn; long-term debt and leases C$4.33bn.
HQ Canada · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2025 revenue C$15.91bn (+8.4%); pre-tax margin 14.1%; net income C$1.66bn.
Net debt C$3.45bn; long-term debt and leases C$4.33bn.
Source: official results release · Year ended 2025-09-30 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | CA$15.9bn | +8.4% | CA$2.2bn | CA$1.7bn | CGI |
Products not yet catalogued.
FY2025 revenue C$15.91bn (+8.4%); pre-tax margin 14.1%; net income C$1.66bn.
Net debt C$3.45bn; long-term debt and leases C$4.33bn.
No adverse media involving CGI found in HSH's search of the last 24 months, apart from the Mar 2026 CGI Sweden security incident (see Cyber & information governance).
Mar 2026: CGI Sweden reported a security incident on two internal test servers that exposed an older version of an application's source code; CGI said there was no indication customer production systems or data were compromised. NHS DSPT status not yet checked.
IT services supplier; no regulatory or clinical safety actions found in the last 24 months.
Jul 2025: CGI (via BJSS, now part of CGI) won a £16.6m, two-year NHS England contract as a strategic partner for its Enabling Products Portfolio (bookings, referrals, medicines). Jun 2026: CGI announced a UK Ministry of Defence SOTERIA contract.
No competitors linked yet.